L'Oreal US Settles Hair Relaxer Cancer Cases During First Trial
Danielle Ward Mason, Partner at Singleton Schreiber, was featured by Reuters in an article titled “L'Oreal US Settles Hair Relaxer Cancer Cases During First Trial,” published on November 16, 2026.
Ward Mason is an attorney for MaryAnne Lindsey, Surenthia Jenkins, Miranda Lofton, and Sandra Simpson. Their cases against L'Oréal's US subsidiary and other manufacturers were the first hair relaxer cases to go to trial. In a statement, Ward Mason said she hoped the settlement would give the women a sense of justice.
The four women filed suit in Cook County, Illinois, in 2023 and 2024. They allege that years of using chemical hair straighteners caused them to develop gynecologic cancers. Trial began on November 9 with jury selection, and the cases settled on November 16 for a confidential sum. More than 12,700 similar cases are centralized in federal court in Chicago. The first lawsuits were filed after a 2022 National Institutes of Health study that found women who used the products several times a year were more than twice as likely to develop uterine cancer. L'Oréal has said the study did not establish a causal link. Arizona and Minnesota have also sued the company over the products this year.